Research map: Vaccination in haematopoietic stem cell transplantation and cellular therapies: consensus, divergence, and uncertainties in global practice

Back to the article

Papers in this map

  1. Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7) · Catherine Cordonnier · 2019 · 334 citations · Cited by this paper
  2. Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMT · Ryszard Swoboda · 2026 · 1 citation · Related
  3. Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors—Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) · C. Rieger · 2018 · 126 citations · Cited by this paper
  4. Allogeneic stem cell transplantation in adult Ph-like acute lymphoblastic leukemia. Results from two consecutive GIMEMA protocols · 2026 · Related
  5. Vaccine schedule recommendations and updates for patients with hematologic malignancy post‐hematopoietic cell transplant or CAR T‐cell therapy · Gemma K. Reynolds · 2023 · 65 citations · Cited by this paper
  6. Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities · 2026 · Related
  7. Joint consensus statement on the vaccination of adult and paediatric haematopoietic stem cell transplant recipients: Prepared on behalf of the British society of blood and marrow transplantation and cellular therapy (BSBMTCT), the Children's cancer and Leukaemia Group (CCLG), and British Infection Association (BIA) · P D E Miller · 2022 · 46 citations · Cited by this paper
  8. Institutional risk management for out-of-specification commercial CAR-T products · 2026 · Related
  9. Robust SARS-CoV-2 T cell responses with common TCRαβ motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells · Thi H. O. Nguyen · 2023 · 25 citations · Cited by this paper
  10. The 52nd Annual Meeting of the European Society for Blood and Marrow Transplantation: Data Management Group – Poster Session (P973–P983) · 2026 · Related
  11. Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies · Sigrun Einarsdottir · 2025 · 16 citations · Cited by this paper
  12. CAR-T TEMRA and CAR-Tregs in vivo expansion are both associated with a poor response after CD19.CAR-T therapy · 2026 · Related
  13. Impact of a dedicated post-transplant vaccination service at an Australian cancer centre · Benjamin W. Teh · 2017 · 12 citations · Cited by this paper
  14. The 52nd Annual Meeting of the European Society for Blood and Marrow Transplantation: Van Bekkum Awards · 2026 · Related
  15. Safety and immunogenicity of adjuvanted respiratory syncytial virus vaccine in high-risk transplant recipients: an interventional cohort study · Victoria G. Hall · 2025 · 12 citations · Cited by this paper
  16. Impact of doublet post-transplant maintenance on outcomes in multiple myeloma: A propensity score matching analysis · 2026 · Related
  17. Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody response · Stosh Ozog · 2026 · 8 citations · Cited by this paper
  18. EASIX and sC5b-9 for early identification of adults at high risk of developing TA-TMA after allo-HCT · 2026 · Related
  19. Respiratory Syncytial Virus Exceeded SARS‐CoV‐2 and Influenza in Lower Respiratory Infection and Mortality Rates Among Patients With Hematologic Malignancies During the 2023–2024 Respiratory Virus Season · Tali Shafat · 2025 · 4 citations · Cited by this paper
  20. Evaluation of a novel eHealth-facilitated, post HCT-integrated care model on implementation and rehospitalization: results from the Swiss SMILe hybrid-RCT · 2026 · Related
  21. Severity of respiratory-syncytial-virus and other respiratory viruses versus seasonal influenza amongst hospitalized cancer patients · Liang En Wee · 2025 · 4 citations · Cited by this paper
  22. Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial · Victoria G. Hall · 2025 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)